Varun Iyengar,Rushad Patell,Jeffrey Zwicker
Varun Iyengar
Venous thromboembolism (VTE) is a common complication in patients with primary and metastatic brain cancer. Treatment of thrombosis in these patients must be balanced against the risk of intracranial hemorrhage (ICH). A number of cohort stu...
Nadim Tawil,Janusz Rak
Nadim Tawil
Cancer associated thrombosis (CAT) including venous and arterial thromboembolism (VTE and ATE respectively), as well as subclinical hypercoagulable states pose a risk of serious morbidity and mortality and poor outcomes in cancer patients. ...
Assaf Arie Barg,Gili Kenet
Assaf Arie Barg
The etiology of pediatric cancer associated thrombosis (CAT) is multifactorial and may reflect pro-coagulant alterations of the hemostatic system induced by presence of cancer itself or by therapeutic chemotherapy, tumor mass effects, tumor...
Benjamin Brenner,Andrés J Muñoz Martín
Benjamin Brenner
Thromboprophylaxis of cancer patients undergoing systemic therapy in the ambulatory setting [0.03%]
门诊接受全身治疗的癌症患者血栓预防措施
L A Ciuffini,T F Wang,C Lodigiani et al.
L A Ciuffini et al.
Cancer-associated Thrombosis (CAT) is a common complication among patients with cancer which is associated with significant morbidity and mortality. The risk of CAT varies widely depending on cancer types and treatments and its cumulative i...
Tzu-Fei Wang,Avi Leader,Kristen M Sanfilippo
Tzu-Fei Wang
Venous (VTE) and arterial (ATE) thromboemboli are a leading cause of morbidity and mortality in patients with cancer. Patients with hematological malignancies are at an exceptionally high risk of both VTE and ATE. This risk varies based on ...
A review of latest clinical practice guidelines for the management of cancer-associated thrombosis [0.03%]
癌症相关血栓管理的最新临床实践指南概述
Corinne Frere,Clementine Wahl,Jose A Rueda-Camino et al.
Corinne Frere et al.
The management of cancer-associated thrombosis (CAT) poses unique challenges to healthcare professionals. While low-molecular weight heparins (LMWHs) have long been the gold standard for both the primary and secondary prevention of CAT, res...
Risk assessment and primary prevention of VTE in patients with cancer: Advances, challenges, and evidence gaps [0.03%]
癌症患者的静脉血栓栓塞的风险评估和一级预防：进展、挑战与证据缺口
Daniel Steiner,Cihan Ay
Daniel Steiner
Venous thromboembolism (VTE) is a common complication in cancer patients, which is associated with increased morbidity and mortality as well as high risk of VTE recurrence and bleeding. Furthermore, it impairs quality of life, interferes wi...
Elena Campello,Floris Bosch,Chiara Simion et al.
Elena Campello et al.
Patients with pancreatic cancer have a very high risk of both venous and arterial thrombosis compared with other cancers, caused by a tumour-driven hypercoagulable state. Better understanding of pancreatic cancer-associated prothrombotic an...
Effectiveness of allogeneic hematopoietic cell transplantation for older patients with acute myeloid leukemia [0.03%]
同种异体造血细胞移植在年老急性髓性白血病患者中的疗效研究
Frederick R Appelbaum
Frederick R Appelbaum
Outcomes with conventional chemotherapy for older patients with acute myeloid leukemia (AML) remain disappointing, with few cures. For younger patients with AML, allogeneic hematopoietic cell transplantation (HCT) offers the best chance for...